Nabil Noureddin

Title(s)Associate Physician, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia. Aliment Pharmacol Ther. 2024 Nov 05. Amangurbanova M, Huang DQ, Noureddin N, Tesfai K, Bettencourt R, Siddiqi H, Lopez SJ, Cervantes V, Madamba E, Loomba R. PMID: 39499168.
      View in: PubMed   Mentions:    Fields:    
    2. Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024 06; 59 Suppl 1:S41-S51. Noureddin N, Copur-Dahi N, Loomba R. PMID: 38813822; PMCID: PMC11141723.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024 06; 59(12):1521-1526. Noureddin N, Huang DQ, Bettencourt R, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Gidener T, Allen AM, Ajmera V, Loomba R. PMID: 38571305.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality. Aliment Pharmacol Ther. 2024 01; 59(1):80-88. Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, Amangurbanova M, Siddiqi H, Madamba E, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Yoneda M, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. PMID: 37968251; PMCID: PMC10807727.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses. Aliment Pharmacol Ther. 2023 11; 58(9):856-865. Noureddin N, Ajmera V, Bergstrom J, Bettencourt R, Huang DQ, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. PMID: 37694993; PMCID: PMC10901230.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. Lancet Gastroenterol Hepatol. 2023 09; 8(9):829-836. Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. PMID: 37419133; PMCID: PMC10812844.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    7. Noninvasive tests in the evaluation of nonalcoholic fatty liver disease: A review. Clin Liver Dis (Hoboken). 2023 Sep; 22(3):103-112. Tun KM, Noureddin N, Noureddin M. PMID: 37799634; PMCID: PMC10550044.
      View in: PubMed   Mentions:
    8. Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatol Commun. 2023 05 01; 7(5). Noureddin M, Mena E, Vuppalanchi R, Samala N, Wong M, Pacheco F, Polanco P, Sakkal C, Antaramian A, Chang D, Noureddin N, Kohli A, Harrison SA, Gawrieh S, Alkhouri N, Truong E. PMID: 37141504; PMCID: PMC10162783.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death. Clin Gastroenterol Hepatol. 2023 09; 21(10):2570-2577.e1. Truong E, Gornbein JA, Yang JD, Noureddin N, Harrison SA, Alkhouri N, Noureddin M. PMID: 36813013.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis. Am J Gastroenterol. 2022 12 01; 117(12):2075-2078. Hercun J, Noureddin M, Noureddin N, Eccleston J, Woolridge D, Liang TJ, Tana M, Kleiner DE, Rodriguez GV, Koh C, Hoofnagle JH, Heller T. PMID: 36066458; PMCID: PMC9722512.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis. Hepatology. 2023 02 01; 77(2):546-557. Chang D, Truong E, Mena EA, Pacheco F, Wong M, Guindi M, Todo TT, Noureddin N, Ayoub W, Yang JD, Kim IK, Kohli A, Alkhouri N, Harrison S, Noureddin M. PMID: 35809234.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    12. MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis. J Hepatol. 2022 Apr; 76(4):781-787. Noureddin M, Truong E, Gornbein JA, Saouaf R, Guindi M, Todo T, Noureddin N, Yang JD, Harrison SA, Alkhouri N. PMID: 34798176.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    13. Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes. Dig Dis Sci. 2022 04; 67(4):1379-1388. Noureddin N, Noureddin M, Singh A, Alkhouri N. PMID: 33779880.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    14. Sex differences in age at wait-list registration for liver transplantation with nonalcoholic steatohepatitis as primary indication. Clin Transplant. 2021 02; 35(2):e14163. Steggerda JA, Noureddin N, Alkhouri N, Todo T, Dong Yang J, Kim IK, Noureddin M. PMID: 33280172.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Driving Nonalcoholic Steatohepatitis Forward Using the FibroScan Aspartate Aminotransferase Score, But Obey the Traffic Lights. Hepatology. 2020 12; 72(6):2228-2230. Noureddin N, Alkhouri N, Brown KA, Noureddin M. PMID: 32757393.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    16. Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 Analysis. Transplant Direct. 2020 Nov; 6(11):e612. Noureddin N, Yang JD, Alkhouri N, Noreen SM, Toll AE, Todo T, Ayoub W, Kuo A, Voidonikolas G, Kotler HG, Pelphrey MD, Durand BJ, Kosari K, Brennan TV, Kim I, Klein AS, Seki E, Nissen NN, Lu SC, Sundaram V, Noureddin M. PMID: 33134488; PMCID: PMC7546885.
      View in: PubMed   Mentions: 1  
    17. Injury, Illness, and Mental Health Risks in United States Domestic Mariners. J Occup Environ Med. 2020 10; 62(10):839-841. Lefkowitz RY, Null DB, Slade MD, Redlich CA. PMID: 32769797.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study. Liver Int. 2020 09; 40(9):2242-2251. Han MAT, Vipani A, Noureddin N, Ramirez K, Gornbein J, Saouaf R, Baniesh N, Cummings-John O, Okubote T, Setiawan VW, Rotman Y, Loomba R, Alkhouri N, Noureddin M. PMID: 32652744.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    19. Imaging examination, diagnosis, and control and prevention of nosocomial infection for coronavirus disease 2019: Expert consensus of Hunan radiologist. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Mar 28; 45(3):221-228. Liu J, Wang W. PMID: 32386011.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    20. Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass? Hepatol Commun. 2020 Feb; 4(2):141-144. Noureddin N, Schattenberg JM, Alkhouri N, Noureddin M. PMID: 32025600; PMCID: PMC6996378.
      View in: PubMed   Mentions: 3     Fields:    
    21. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale. Catheter Cardiovasc Interv. 2020 02 15; 95(3):365-372. Gevorgyan Fleming R, Kumar P, West B, Noureddin N, Rusheen J, Aboulhosn J, Tobis JM. PMID: 31654558.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. Fibrosis Changes in the Placebo Arm of NASH Clinical Trials. Clin Gastroenterol Hepatol. 2019 10; 17(11):2387. Altayar O, Noureddin N, Thanda Han MA, Murad MH, Noureddin M. PMID: 31543242.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke. Stroke. 2018 05; 49(5):1123-1128. West BH, Noureddin N, Mamzhi Y, Low CG, Coluzzi AC, Shih EJ, Gevorgyan Fleming R, Saver JL, Liebeskind DS, Charles A, Tobis JM. PMID: 29636424; PMCID: PMC5915909.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    24. Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort. Clin Gastroenterol Hepatol. 2017 08; 15(8):1305-1307. Setiawan VW, Porcel J, Wei P, Stram DO, Noureddin N, Lu SC, Le Marchand L, Noureddin M. PMID: 28300689; PMCID: PMC5522625.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Usefulness of Transcranial Doppler for Detecting Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. Am J Cardiol. 2016 Apr 01; 117(7):1180-4. Kijima Y, Gevorgyan R, McWilliams JP, Miller N, Noureddin N, Tobis JM. PMID: 26873746.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Sleep Apnea in Patients with and without a Right-to-Left Shunt. J Clin Sleep Med. 2015 Nov 15; 11(11):1299-304. Mojadidi MK, Bokhoor PI, Gevorgyan R, Noureddin N, MacLellan WC, Wen E, Aysola R, Tobis JM. PMID: 26094924; PMCID: PMC4623128.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome. Catheter Cardiovasc Interv. 2015 Oct; 86(4):701-7. Mojadidi MK, Gevorgyan R, Noureddin N, Tobis JM. PMID: 26063336.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    Nabil's Networks
    Concepts (96)
    Derived automatically from this person's publications.
    _
    Co-Authors (405)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _